Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zanichelli

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Annals of Hematology|November 11, 2008
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year studyE M Souza, O C G Baiocchi, M A Zanichelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 4, 2017
The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countriesT Caballero, W Aberer, H J Longhurst, et al.
Journal of Internal Medicine|September 9, 2014
Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patientsM Mansi, A Zanichelli, A Coerezza, et al.
Clinical and Experimental Immunology|December 10, 2016
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome SurveyH J Longhurst, A Zanichelli, T Caballero, et al.
Allergy|February 14, 2016
Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedemaS Loffredo, M Bova, C Suffritti, et al.
Allergy|August 26, 2015
Efficacy of on-demand treatment in reducing morbidity in patients with hereditary angioedema due to C1 inhibitor deficiencyA Zanichelli, M Mansi, G M Azin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 10, 2021
Variability of disease activity in patients with hereditary angioedema type 1/2: longitudinal data from the Icatibant Outcome SurveyM Maurer, T Caballero, W Aberer, et al.
Allergy|August 10, 2016
International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiencyH Farkas, I Martinez-Saguer, K Bork, et al.
Hematological Oncology|February 4, 2010
Impact of Epstein-Barr virus in the clinical evolution of patients with classical Hodgkin's lymphoma in BrazilEni M Souza, Otávio C G Baiocchi, Maria A Zanichelli, et al.
Medical Oncology (Northwood, London, England)|September 17, 2011
Matrix metalloproteinase-9 is consistently expressed in Hodgkin/Reed-Sternberg cells and has no impact on survival in patients with Epstein-Barr virus (EBV)-related and non-related Hodgkin lymphoma in BrazilEni M Souza, Otávio C G Baiocchi, Maria A Zanichelli, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Annals of Hematology|November 11, 2008
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year studyE M Souza, O C G Baiocchi, M A Zanichelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 4, 2017
The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countriesT Caballero, W Aberer, H J Longhurst, et al.
Journal of Internal Medicine|September 9, 2014
Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patientsM Mansi, A Zanichelli, A Coerezza, et al.
Clinical and Experimental Immunology|December 10, 2016
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome SurveyH J Longhurst, A Zanichelli, T Caballero, et al.
Allergy|February 14, 2016
Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedemaS Loffredo, M Bova, C Suffritti, et al.
Allergy|August 26, 2015
Efficacy of on-demand treatment in reducing morbidity in patients with hereditary angioedema due to C1 inhibitor deficiencyA Zanichelli, M Mansi, G M Azin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 10, 2021
Variability of disease activity in patients with hereditary angioedema type 1/2: longitudinal data from the Icatibant Outcome SurveyM Maurer, T Caballero, W Aberer, et al.
Allergy|August 10, 2016
International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiencyH Farkas, I Martinez-Saguer, K Bork, et al.
Hematological Oncology|February 4, 2010
Impact of Epstein-Barr virus in the clinical evolution of patients with classical Hodgkin's lymphoma in BrazilEni M Souza, Otávio C G Baiocchi, Maria A Zanichelli, et al.
Medical Oncology (Northwood, London, England)|September 17, 2011
Matrix metalloproteinase-9 is consistently expressed in Hodgkin/Reed-Sternberg cells and has no impact on survival in patients with Epstein-Barr virus (EBV)-related and non-related Hodgkin lymphoma in BrazilEni M Souza, Otávio C G Baiocchi, Maria A Zanichelli, et al.
Pageof 4